Read article—Dartmouth Cancer Center researchers report that telmisartan, a common blood pressure medication, can help certain cancer treatments called PARP inhibitors work more effectively.
Articles by: Geisel Communications
Hunt to Lead Geisel School of Medicine—Bonner County Daily Bee
Read article—Announcement of Jennifer Hunt, a native of Sandpoint, Idaho, as the new dean of the Geisel School of Medicine and the first woman to lead the school in its 229-year history. “It is an honor and a privilege to be joining the vibrant Dartmouth community,” Hunt said.
U.S. News Unveils 2026 Best Graduate Schools—U.S News & World Report
Read article—The Geisel School of Medicine is ranked in Tier 1 in U.S. News & World Report’s 2026 best medical schools for primary care. (Similar coverage in MedPage Today, Becker’s Hospital Review, and University Business.)
Could a Blood Pressure Pill Improve the Health of Cancer Patients? Here’s What to Know—PennLive
Read article—Tyler Curiel, a professor of medicine, talks about his study reporting that the blood-pressure medicine Telmisartan may enhance the efficacy of cancer treatments known as PARP inhibitors. “This study shows that a common, safe, tolerable, convenient, and inexpensive drug may significantly improve how well an important class of cancer therapies works,” Curiel said.
Dr. Jennifer Hunt Appointed Geisel School of Medicine Dean—Valley News
Read article—Quotes Provost Santiago Schnell in an article highlighting Dartmouth’s Geisel School of Medicine’s newly appointed dean, Jennifer Hunt. Hunt is the first woman to lead the medical school, making history about three years after President Sian Leah Beilock became the first woman elected to lead the university. (Picked up by NHPR.)
Is Brain Health the Next Health Care Frontier?—TIME
Read article—John Randolph, a clinical assistant professor of psychiatry, is cited in an opinion piece by Ariana Huffington, the CEO of Thrive Global, on brain health and performance. “The bottom line is that memory impairment is definitely not part of the typical aging process for most of us,” Randolph wrote in The Brain Health Book. “It’s almost the opposite: the brain continues to grow and adapt throughout life, into our eighties and beyond.”
Jennifer Hunt Named Dean of Geisel School of Medicine
Internationally recognized pathologist and physician-scientist Jennifer Hunt, MD, MEd, has been named the next dean of the Geisel School of Medicine, Provost Santiago Schnell and President Sian Leah Beilock announced today. She begins the role on Aug. 1.
Dartmouth Cancer Center Names New Director—Valley News
Read article—Roy Herbst will be the new director of the Dartmouth Cancer Center. Herbst will begin his role July 13 and replaces Konstantin Dragnev, who was appointed interim director of the cancer center last October.
MRIs May Benefit Patients With Dense Breasts at High Cancer Risk—Healio
Read article—Anna N. A. Tosteson, a professor of health policy and clinical practice, medicine, and community and family medicine, is featured in an article about best screening practices for patients with extremely dense breasts and higher cancer risk. “Clinicians can be attentive to women’s breast density and breast cancer risk, and discuss both the benefits and harms of breast cancer screening,” Tosteson said.
Catheter-Directed Thrombolysis Superior to Anticoagulation for Acute Pulmonary Embolism—Healio
Read article—Mark Creager, a professor of medicine and surgery, provides a perspective on new research that found catheter-directed thrombolysis plus anticoagulation improved outcomes in acute intermediate-risk pulmonary embolism. “This and other upcoming trial results are going to be very important as we think about guideline recommendations in the future,” Creager said.